These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 25875045)

  • 1. Involvement of mTOR in Type 2 CRF Receptor Inhibition of Insulin Signaling in Muscle Cells.
    Chao H; Li H; Grande R; Lira V; Yan Z; Harris TE; Li C
    Mol Endocrinol; 2015 Jun; 29(6):831-41. PubMed ID: 25875045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
    Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
    Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.
    Veilleux A; Houde VP; Bellmann K; Marette A
    Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
    Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M
    Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.
    Khamzina L; Veilleux A; Bergeron S; Marette A
    Endocrinology; 2005 Mar; 146(3):1473-81. PubMed ID: 15604215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTOR partly mediates insulin resistance by phosphorylation of insulin receptor substrate-1 on serine(307) residues after burn.
    Xin-Long C; Zhao-Fan X; Dao-Feng B; Wei D
    Burns; 2011 Feb; 37(1):86-93. PubMed ID: 20594757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical effect of rapamycin on inflammatory stress-induced insulin resistance in vitro and in vivo.
    Yang P; Zhao Y; Zhao L; Yuan J; Chen Y; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
    Sci Rep; 2015 Oct; 5():14959. PubMed ID: 26449763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-binding EGF-like growth factor (HB-EGF) mediates 5-HT-induced insulin resistance through activation of EGF receptor-ERK1/2-mTOR pathway.
    Li Q; Hosaka T; Shikama Y; Bando Y; Kosugi C; Kataoka N; Nakaya Y; Funaki M
    Endocrinology; 2012 Jan; 153(1):56-68. PubMed ID: 22028447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved insulin sensitivity by rapamycin is associated with reduction of mTOR and S6K1 activities in L6 myotubes.
    Hwang SL; Li X; Lee JY; Chang HW
    Biochem Biophys Res Commun; 2012 Feb; 418(2):402-7. PubMed ID: 22281494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced skeletal muscle insulin sensitivity after acute resistance-type exercise is upregulated by rapamycin-sensitive mTOR complex 1 inhibition.
    Kido K; Sase K; Yokokawa T; Fujita S
    Sci Rep; 2020 May; 10(1):8509. PubMed ID: 32444657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
    Fang CX; Yang X; Sreejayan N; Ren J
    Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake.
    Ginion A; Auquier J; Benton CR; Mouton C; Vanoverschelde JL; Hue L; Horman S; Beauloye C; Bertrand L
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H469-77. PubMed ID: 21602475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urocortin 2 modulates glucose utilization and insulin sensitivity in skeletal muscle.
    Chen A; Brar B; Choi CS; Rousso D; Vaughan J; Kuperman Y; Kim SN; Donaldson C; Smith SM; Jamieson P; Li C; Nagy TR; Shulman GI; Lee KF; Vale W
    Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16580-5. PubMed ID: 17050686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceramide inhibits insulin-stimulated Akt phosphorylation through activation of Rheb/mTORC1/S6K signaling in skeletal muscle.
    Hsieh CT; Chuang JH; Yang WC; Yin Y; Lin Y
    Cell Signal; 2014 Jul; 26(7):1400-8. PubMed ID: 24650522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin ameliorates high uric acid-induced insulin resistance in skeletal muscle cells.
    Yuan H; Hu Y; Zhu Y; Zhang Y; Luo C; Li Z; Wen T; Zhuang W; Zou J; Hong L; Zhang X; Hisatome I; Yamamoto T; Cheng J
    Mol Cell Endocrinol; 2017 Mar; 443():138-145. PubMed ID: 28042024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation.
    Tzatsos A; Kandror KV
    Mol Cell Biol; 2006 Jan; 26(1):63-76. PubMed ID: 16354680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine modulates phosphorylation of insulin receptor substrate-1 and impairs insulin signal transduction in rat skeletal muscle.
    Egawa T; Tsuda S; Ma X; Hamada T; Hayashi T
    J Appl Physiol (1985); 2011 Dec; 111(6):1629-36. PubMed ID: 21940847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnosic Acid Attenuates the Free Fatty Acid-Induced Insulin Resistance in Muscle Cells and Adipocytes.
    Den Hartogh DJ; Vlavcheski F; Giacca A; MacPherson REK; Tsiani E
    Cells; 2022 Jan; 11(1):. PubMed ID: 35011728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling.
    Martin KA; Merenick BL; Ding M; Fetalvero KM; Rzucidlo EM; Kozul CD; Brown DJ; Chiu HY; Shyu M; Drapeau BL; Wagner RJ; Powell RJ
    J Biol Chem; 2007 Dec; 282(49):36112-20. PubMed ID: 17908691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
    Batty IH; Fleming IN; Downes CP
    Biochem J; 2004 May; 379(Pt 3):641-51. PubMed ID: 14769130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.